insights_auto
Zašto je 603259 pao 6,60%?
Istražite detaljnijechevron_right
603259:SHA
WuXi AppTec Co Ltd
144,30 CNY
arrow_downward
−6,60%(−10,20) 1D
16. lis, 15:00:01 GMT+8 · CNY
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 603259...
Otvori
156,94 CNY
Najviša
159,92 CNY
Najniža
139,05 CNY
Trž. kap.
474,75 mlr.
Prosj. kol.
34,02 mil.
Količina
83,61 mil.
Dividenda
1,45 %
Kvartalna dividenda
0,52 CNY
Datum nakon isplate dividende
4. ruj 2026.
P/E omjer
19,63
52-tjed. najviša
173,60 CNY
52-tjed. najniža
87,09 CNY
EPS
7,35 CNY
Dionice u optjecaju
1,05 mlr.
Broj djelatnika
36 tis.
Otvori
156,94 CNY
Najviša
159,92 CNY
Najniža
139,05 CNY
Trž. kap.
474,75 mlr.
Prosj. kol.
34,02 mil.
Količina
83,61 mil.
Dividenda
1,45 %
Kvartalna dividenda
0,52 CNY
Datum nakon isplate dividende
4. ruj 2026.
P/E omjer
19,63
52-tjed. najviša
173,60 CNY
52-tjed. najniža
87,09 CNY
EPS
7,35 CNY
Dionice u optjecaju
1,05 mlr.
Broj djelatnika
36 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 1 dan
Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40
ad-hoc-news.de
·
prije 2 dana
Morgan Stanley backs 800-ton expansion for WuXi AppTec stock
ad-hoc-news.de
·
prije 2 dana
Morgan Stanley keeps HKD 207.40 target for WuXi AppTec stock
ad-hoc-news.de
·
prije 3 dana
Huaxi Securities maintains Buy for WuXi AppTec stock
Profil
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
WuXi AppTec Co Ltd – informacije
Glavni izvršni direktorSteve Yang | Ge Li
Zaposlenici35,6 tis.
Osnovano1. pro 2000.
Sjedište-
Sektor-
Web-lokacijawuxiapptec.com.cn